Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Bhatt, J. R. & Finelli, A. Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat. Rev. Urol. 11, 517–525 (2014).

Article  PubMed  Google Scholar 

Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Prim. 3, 17009 (2017).

Article  PubMed  Google Scholar 

Moch, H. et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs – part a: renal, penile, and testicular tumours. Eur. Urol. 82, 458–468 (2022).

Article  PubMed  Google Scholar 

Zhang, Q., Yan, Q., Yang, H. & Wei, W. Oxygen sensing and adaptability won the 2019 Nobel Prize in Physiology or medicine. Genes. Dis. 6, 328–332 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao, C. & Zhang, Q. Understanding the oxygen-sensing pathway and its therapeutic implications in diseases. Am. J. Pathol. 190, 1584–1595 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao, C., Liu, X., Zhang, C. & Zhang, Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin. Cancer Biol. 88, 172–186 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, J. & Zhang, Q. VHL and hypoxia signaling: beyond HIF in cancer. Biomedicines 6, 35 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Aghamir, S. M. K. et al. The impact of succinate dehydrogenase gene (SDH) mutations in renal cell carcinoma (RCC): a systematic review. OncoTargets Ther. 12, 7929–7940 (2019).

Article  CAS  Google Scholar 

Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143–153 (2005).

Article  CAS  PubMed  Google Scholar 

Wang, G. L. & Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230–1237 (1995).

Article  CAS  PubMed  Google Scholar 

Tian, H., McKnight, S. L. & Russell, D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes. Dev. 11, 72–82 (1997).

Article  CAS  PubMed  Google Scholar 

Ema, M. et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA 94, 4273–4278 (1997).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu, Y. Z., Moran, S. M., Hogenesch, J. B., Wartman, L. & Bradfield, C. A. Molecular characterization and chromosomal localization of a third ɑ-class hypoxia inducible factor subunit, HIF3ɑ. Gene Expr. 7, 205–213 (1998).

CAS  PubMed  Google Scholar 

Lin, F. K. et al. Cloning and expression of the human erythropoietin gene. Proc. Natl Acad. Sci. USA 82, 7580–7584 (1985).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semenza, G. L., Nejfelt, M. K., Chi, S. M. & Antonarakis, S. E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene. Proc. Natl Acad. Sci. USA 88, 5680–5684 (1991).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor-1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O-2 tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaelin, W. G. Jr Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb. Symp. Quant. Biol. 76, 335–345 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albadari, N., Deng, S. S. & Li, W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert. Opin. Drug. Dis. 14, 667–682 (2019).

Article  CAS  Google Scholar 

Wiesener, M. S. et al. Widespread hypoxia-inducible expression of HIF-2ɑ in distinct cell populations of different organs. FASEB J. 17, 271–273 (2003).

Article  CAS  PubMed  Google Scholar 

Raval, R. R. et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell Biol. 25, 5675–5686 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schodel, J. et al. Hypoxia, hypoxia-inducible transcription factors, and renal cancer. Eur. Urol. 69, 646–657 (2016).

Article  PubMed  Google Scholar 

Gordan, J. D. et al. HIF-ɑ effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14, 435–446 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kondo, K., Kim, W. Y., Lechpammer, M. & Kaelin, W. G. Jr Inhibition of HIF2ɑ is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83 (2003).

Article  PubMed  PubMed Central  Google Scholar 

Zimmer, M., Doucette, D., Siddiqui, N. & Iliopoulos, O. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors. Mol. Cancer Res. 2, 89–95 (2004).

Article  CAS  PubMed  Google Scholar 

Qiu, B. et al. HIF2ɑ-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5, 652–667 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. & Kaelin, W. G. Jr Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237–246 (2002).

Article  CAS  PubMed  Google Scholar 

Monzon, F. A. et al. Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis. Mod. Pathol. 24, 1470–1479 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen, C. et al. Genetic and functional studies implicate HIF1ɑ as a 14q kidney cancer suppressor gene. Cancer Discov. 1, 222–235 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoefflin, R. et al. HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice. Nat. Commun. 11, 4111 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cockman, M. E. et al. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733–25741 (2000).

Article  CAS  PubMed  Google Scholar 

Yu, F., White, S. B., Zhao, Q. & Lee, F. S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl Acad. Sci. USA 98, 9630–9635 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fong, G. H. & Takeda, K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15, 635–641 (2008).

Article  CAS  PubMed  Google Scholar 

Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634 (2010).

Article  CAS  PubMed  Google Scholar 

McDermott, D. F. et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 23, 133–141 (2005).

Article  CAS  PubMed  Google Scholar 

Chen, Y. W., Rini, B. I. & Beckermann, K. E. Emerging targets in clear cell renal cell carcinoma. Cancers 14, 4843 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar